Antiretroviral News and Research

RSS

Study highlights long-term benefits of early antiretroviral therapy initiated in infants

A study led by University of Massachusetts Medical School professor and immunologist Katherine Luzuriaga, MD, and Johns Hopkins Children's Center virologist Deborah Persaud, MD, highlights the long-term benefits of early antiretroviral therapy (ART) initiated in infants.

5 Mar 2013

HCV and HIV co-infected patients achieve early treatment success with faldaprevir, PegIFN/RBV

Interim study results from STARTversoTM 4 presented today at CROI+ show that 80 percent of hepatitis C (HCV) patients also infected with HIV achieved early treatment success with faldaprevir (BI 201335) combined with pegylated interferon and ribavirin (PegIFN/RBV).

5 Mar 2013

HIV infection may increase risk of acute myocardial infarction

A study that analyzed data from more than 82,000 veterans suggests that infection with the human immunodeficiency virus (HIV) was associated with an increased risk of acute myocardial infarction (AMI, heart attack) beyond what is explained by recognized risk factors, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.

4 Mar 2013

Prompt antiretroviral therapy may help infants clear the HIV and achieve long-term remission

A team of researchers from Johns Hopkins Children's Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School describe the first case of a so-called "functional cure" in an HIV-infected infant. The finding, the investigators say, may help pave the way to eliminating HIV infection in children.

4 Mar 2013

UNAIDS, UNDP release issue brief on TRIPS transition period extensions for LDCs

"The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations Development Programme (UNDP) today launched a new issue brief", titled "TRIPS transition period extensions for least-developed countries [LDCs]," a UNAIDS press release reports.

28 Feb 2013

Using smart phones to manage HIV treatment in rural Virginia

An innovative plan developed at the University of Virginia School of Medicine will use smart phones to improve care for people recently diagnosed with HIV in rural Virginia.

27 Feb 2013

AIDS activists work to influence Kenyan presidential candidates' positions on care, treatment

"A small team of HIV/AIDS activists is trailing Kenyan presidential candidates as they crisscross the country, pressing them to increase their commitment to the care and treatment of people living with HIV," PlusNews reports.

27 Feb 2013

Kaposi’s sarcoma risk factors revealed

Scientists have uncovered an intriguing relationship between the risk for Kaposi’s sarcoma, smoking, and the use of highly active antiretroviral therapy.

25 Feb 2013

Comprehensive portfolio of antiretroviral products from Mylan

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products.

25 Feb 2013

HIV epidemics and extra-couple relationships: an interview with Steve Bellan, University of Texas

The epicentre of the HIV pandemic is in sub-Saharan Africa, though prevalence of infection varies dramatically between countries for reasons not completely understood.

25 Feb 2013

Widespread ART coverage can reduce risk of HIV infection, increase life expectancy of general population, studies show

"An intensive campaign to combat HIV/AIDS with costly antiretroviral drugs in rural South Africa has increased life expectancy by more than 11 years and significantly reduced the risk of infection for healthy individuals, according to new research," the Los Angeles Times reports.

23 Feb 2013

Viewpoints: Holtz-Eakin and Roy offer prescription to fix health law; Iowa lawmakers opposed to Medicaid expansion should give up their coverage

Over nearly a century, progressives have pressed for a national, single-payer healthcare system. When it comes to health reform, what have conservatives stood for? For far too long, conservatives have failed to coalesce around a long-term vision of what a free-market healthcare system should look like. ... Obamacare is the logical byproduct of this conservative policy neglect.

22 Feb 2013

HIV prevention: don’t just target serodiscordant couples

A large proportion of heterosexual HIV transmission in sub-Saharan Africa occurs among stable couples who have sexual partners outside of their relationship, shows research published in The Lancet.

8 Feb 2013

UCSD receives $3.4M NIMH grant to study successful aging in HIV-infected adults

The National Institute of Mental Health has awarded a $3.4 million grant to a team of researchers at the University of California, San Diego School of Medicine to study successful aging in HIV-infected adults. HIV is a serious, chronic, medical disease that affects the lives of more than one million Americans.

5 Feb 2013

Gilead Sciences fourth quarter total revenues increase 18% to $2.59 billion

Gilead Sciences, Inc. announced today its results of operations for the fourth quarter and full year 2012.

5 Feb 2013

HIV infection rate in MSM in England and Wales remains unchanged despite improved prevention measures

The rate of new HIV infections among men who have sex with men (MSM) in England and Wales has remained unchanged over the past decade despite an almost four-fold increase in HIV testing, rising treatment coverage, and a 20% shortening of time-to-diagnosis, according to new research published Online First in The Lancet Infectious Diseases.

1 Feb 2013

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

Merck, known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2012.

1 Feb 2013

HIV-positive patients have higher incidence of non-melanoma skin cancers

HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative.

30 Jan 2013

Gilead commences first of two tenofovir alafenamide Phase 3 trials in HIV

Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.

28 Jan 2013

Novel way to engineer specialized immune cells targeted by the AIDS virus

Researchers at the Stanford University School of Medicine have found a novel way to engineer key cells of the immune system so they remain resistant to infection with HIV, the virus that causes AIDS.

23 Jan 2013

Antiretroviral News and Research

Study highlights long-term benefits of early antiretroviral therapy initiated in infants

HCV and HIV co-infected patients achieve early treatment success with faldaprevir, PegIFN/RBV

HIV infection may increase risk of acute myocardial infarction

Prompt antiretroviral therapy may help infants clear the HIV and achieve long-term remission

UNAIDS, UNDP release issue brief on TRIPS transition period extensions for LDCs

Using smart phones to manage HIV treatment in rural Virginia

AIDS activists work to influence Kenyan presidential candidates' positions on care, treatment

Kaposi’s sarcoma risk factors revealed

Comprehensive portfolio of antiretroviral products from Mylan

HIV epidemics and extra-couple relationships: an interview with Steve Bellan, University of Texas

Widespread ART coverage can reduce risk of HIV infection, increase life expectancy of general population, studies show

Viewpoints: Holtz-Eakin and Roy offer prescription to fix health law; Iowa lawmakers opposed to Medicaid expansion should give up their coverage

HIV prevention: don’t just target serodiscordant couples

UCSD receives $3.4M NIMH grant to study successful aging in HIV-infected adults

Gilead Sciences fourth quarter total revenues increase 18% to $2.59 billion

HIV infection rate in MSM in England and Wales remains unchanged despite improved prevention measures

Merck full-year 2012 worldwide sales decrease 2% to $47.3 billion

HIV-positive patients have higher incidence of non-melanoma skin cancers

Gilead commences first of two tenofovir alafenamide Phase 3 trials in HIV

Novel way to engineer specialized immune cells targeted by the AIDS virus

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News